Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
HumanPheno	Tongue muscle weakness	SH3TC2 PLCB4 ATP13A2	1.95e-05	13	22	3	HP:0000183
HumanPheno	Psychotic episodes	MTHFR USP48 ATP13A2	5.47e-05	18	22	3	HP:0000725
Domain	Beta-tubulin_BS	TUBB6 TUBB3	3.91e-04	10	56	2	IPR013838
Domain	Beta_tubulin	TUBB6 TUBB3	3.91e-04	10	56	2	IPR002453
Domain	TUBULIN_B_AUTOREG	TUBB6 TUBB3	4.77e-04	11	56	2	PS00228
Domain	-	TUBB6 TUBB3	1.62e-03	20	56	2	3.30.1330.20
Domain	-	TUBB6 TUBB3	1.79e-03	21	56	2	1.10.287.600
Domain	Tubulin_C	TUBB6 TUBB3	1.96e-03	22	56	2	SM00865
Domain	Tubulin_C	TUBB6 TUBB3	1.96e-03	22	56	2	PF03953
Domain	Tubulin/FtsZ_2-layer-sand-dom	TUBB6 TUBB3	1.96e-03	22	56	2	IPR018316
Domain	-	TUBB6 TUBB3	1.96e-03	22	56	2	3.40.50.1440
Domain	Tubulin_C	TUBB6 TUBB3	2.15e-03	23	56	2	IPR023123
Domain	TUBULIN	TUBB6 TUBB3	2.15e-03	23	56	2	PS00227
Domain	Tubulin	TUBB6 TUBB3	2.15e-03	23	56	2	IPR000217
Domain	Tub_FtsZ_C	TUBB6 TUBB3	2.15e-03	23	56	2	IPR008280
Domain	Tubulin	TUBB6 TUBB3	2.15e-03	23	56	2	SM00864
Domain	Tubulin_CS	TUBB6 TUBB3	2.15e-03	23	56	2	IPR017975
Domain	Tubulin_FtsZ_GTPase	TUBB6 TUBB3	2.34e-03	24	56	2	IPR003008
Domain	Tubulin	TUBB6 TUBB3	2.34e-03	24	56	2	PF00091
Pathway	KEGG_GAP_JUNCTION	TUBB6 TUBB3 EGF PLCB4	1.89e-04	90	45	4	M4013
Pathway	REACTOME_AGGREPHAGY	TUBB6 TUBB3 DYNC1H1	2.02e-04	36	45	3	MM15669
Pathway	KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT	TUBB6 TUBB3 DYNC1H1	3.43e-04	43	45	3	M47773
Pathway	REACTOME_AGGREPHAGY	TUBB6 TUBB3 DYNC1H1	3.67e-04	44	45	3	M29830
Pathway	REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	TUBB6 TUBB3 DYNC1H1	4.76e-04	48	45	3	MM15353
Pathway	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	TUBB6 LGMN TUBB3 DYNC1H1	5.00e-04	116	45	4	MM14855
Pathway	BIOCARTA_CBL_PATHWAY	EGF SH3KBP1	5.38e-04	11	45	2	MM1360
Pathway	REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND	TUBB6 TUBB3 DYNC1H1	6.02e-04	52	45	3	MM14949
Pathway	REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC	TUBB6 TUBB3 DYNC1H1	6.37e-04	53	45	3	M27651
Pathway	BIOCARTA_CBL_PATHWAY	EGF SH3KBP1	6.44e-04	12	45	2	M16973
Pathway	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	TUBB6 LGMN TUBB3 DYNC1H1	6.83e-04	126	45	4	M705
Pathway	REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND	TUBB6 TUBB3 DYNC1H1	7.88e-04	57	45	3	M27251
Pubmed	Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.	TUBB6 TUBB3	2.83e-06	2	59	2	22438565
Pubmed	Cocaine Blocks Effects of Hunger Hormone, Ghrelin, Via Interaction with Neuronal Sigma-1 Receptors.	GHSR SIGMAR1	2.83e-06	2	59	2	29876881
Pubmed	EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells.	EGF PLAUR	2.83e-06	2	59	2	28849196
Pubmed	Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.	NPHS1 PLAUR	2.83e-06	2	59	2	26380915
Pubmed	Constitutive and ghrelin-dependent GHSR1a activation impairs CaV2.1 and CaV2.2 currents in hypothalamic neurons.	GHSR CACNA1A	1.69e-05	4	59	2	26283199
Pubmed	FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.	TUBB6 TUBB3	2.82e-05	5	59	2	31473790
Pubmed	CD2AP regulates SUMOylation of CIN85 in podocytes.	NPHS1 SH3KBP1	2.82e-05	5	59	2	22203040
Pubmed	CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.	NPHS1 SH3KBP1	2.82e-05	5	59	2	20457601
Pubmed	LIS1 and NDEL1 coordinate the plus-end-directed transport of cytoplasmic dynein.	TUBB3 DYNC1H1	4.23e-05	6	59	2	18784752
Pubmed	Spatiotemporal Role of Transforming Growth Factor Beta 2 in Developing and Mature Mouse Hindbrain Serotonergic Neurons.	TUBB3 FEV	4.23e-05	6	59	2	31619968
Pubmed	EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.	EGF PLAUR	4.23e-05	6	59	2	19020743
Pubmed	The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas.	TUBB3 SH2D3C	5.91e-05	7	59	2	20603213
Pubmed	Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients.	NPHS1 MTHFR	5.91e-05	7	59	2	19520069
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	TAOK2 TUBB6 SH3KBP1 DYNC1H1 FBXO2	6.85e-05	251	59	5	27507650
Pubmed	Fibroblast growth factor receptor signaling promotes radial glial identity and interacts with Notch1 signaling in telencephalic progenitors.	TUBB3 EGF	7.87e-05	8	59	2	15509736
Pubmed	Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.	EGF SH3KBP1	7.87e-05	8	59	2	16407834
Pubmed	Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.	EGF SH3KBP1	7.87e-05	8	59	2	11894095
Pubmed	A novel podocyte gene, semaphorin 3G, protects glomerular podocyte from lipopolysaccharide-induced inflammation.	NPHS1 TUBB3	7.87e-05	8	59	2	27180624
Pubmed	UTX deficiency in neural stem/progenitor cells results in impaired neural development, fetal ventriculomegaly, and postnatal death.	TUBB3 UTY	7.87e-05	8	59	2	36412518
Pubmed	Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities.	TUBB6 TUBB3	7.87e-05	8	59	2	23246003
Pubmed	Mutations in dynein link motor neuron degeneration to defects in retrograde transport.	TUBB3 DYNC1H1	7.87e-05	8	59	2	12730604
Pubmed	Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database.	EGF SIGMAR1 MTHFR	9.66e-05	52	59	3	18583979
Pubmed	Ataxin-3 promotes genome integrity by stabilizing Chk1.	TUBB3 DYNC1H1	1.01e-04	9	59	2	28180282
Pubmed	UTX regulates mesoderm differentiation of embryonic stem cells independent of H3K27 demethylase activity.	TUBB3 UTY	1.01e-04	9	59	2	22949634
Pubmed	PEX14 is required for microtubule-based peroxisome motility in human cells.	TUBB6 TUBB3 DYNC1H1	1.08e-04	54	59	3	21525035
Pubmed	Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor.	EGF PLAUR	1.54e-04	11	59	2	7743917
Pubmed	Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.	EGF SH3KBP1	1.54e-04	11	59	2	15962011
Pubmed	Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.	EGF MTHFR	1.85e-04	12	59	2	16407418
Pubmed	USP11 deubiquitinates RAE1 and plays a key role in bipolar spindle formation.	TUBB3 DYNC1H1	1.85e-04	12	59	2	29293652
Pubmed	The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.	TUBB6 TUBB3	1.85e-04	12	59	2	15331610
Pubmed	Identification of candidate proteins binding to prion protein.	MTHFR FBXO2	1.85e-04	12	59	2	9173930
Pubmed	HIV-1 rev depolymerizes microtubules to form stable bilayered rings.	TUBB6 TUBB3	2.18e-04	13	59	2	10908577
Pubmed	Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.	EGF SH3KBP1	2.18e-04	13	59	2	12218189
Pubmed	Fbxo2VHC mouse and embryonic stem cell reporter lines delineate in vitro-generated inner ear sensory epithelia cells and enable otic lineage selection and Cre-recombination.	TUBB3 FBXO2	2.18e-04	13	59	2	30179592
Pubmed	HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim.	TUBB6 TUBB3	2.54e-04	14	59	2	12486001
Pubmed	Ascl1/Mash1 is required for the development of central serotonergic neurons.	TUBB3 FEV	2.54e-04	14	59	2	15133515
Pubmed	IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration.	ELP2 DYNC1H1	2.93e-04	15	59	2	18303054
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	EPN3 NPHS1 TUBB6 SCRN2 EGF CRNN TTYH3 DYNC1H1	3.06e-04	1016	59	8	19056867
Pubmed	Protein interaction discovery using parallel analysis of translated ORFs (PLATO).	SH2D3C PLAUR TTYH3	3.22e-04	78	59	3	23503679
Pubmed	The SRC homology 2 domain protein Shep1 plays an important role in the penetration of olfactory sensory axons into the forebrain.	TUBB3 SH2D3C	3.34e-04	16	59	2	20881139
Pubmed	Deletion of RIC8A in neural precursor cells leads to altered neurogenesis and neonatal lethality of mouse.	TUBB3 ZFPM2	3.34e-04	16	59	2	25641781
Pubmed	Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing.	TUBB3 TNRC6B	4.25e-04	18	59	2	30111840
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	TUBB6 LGMN TUBB3 EGF TMC4 TTYH3 DYNC1H1 STK25	4.32e-04	1070	59	8	23533145
Pubmed	Inactivation of the GATA Cofactor ZFPM1 Results in Abnormal Development of Dorsal Raphe Serotonergic Neuron Subtypes and Increased Anxiety-Like Behavior.	FEV ZFPM2	4.75e-04	19	59	2	33046550
Pubmed	Ongoing roles of Phox2 homeodomain transcription factors during neuronal differentiation.	TUBB3 FEV	4.75e-04	19	59	2	21068058
Pubmed	ARX regulates cortical intermediate progenitor cell expansion and upper layer neuron formation through repression of Cdkn1c.	TUBB6 TUBB3	4.75e-04	19	59	2	23968833
Pubmed	Neurogenin3 restricts serotonergic neuron differentiation to the hindbrain.	TUBB3 FEV	5.27e-04	20	59	2	25392491
Pubmed	Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models.	TUBB3 DYNC1H1	5.27e-04	20	59	2	36551904
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TAOK2 EPN3 STK10 MTHFR TTYH3 MARVELD3 ATP13A2 DYNC1H1	5.34e-04	1105	59	8	35748872
Pubmed	Insm1 (IA-1) is an essential component of the regulatory network that specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain.	TUBB3 FEV	5.82e-04	21	59	2	19542360
Pubmed	Neuronal-Specific TUBB3 Is Not Required for Normal Neuronal Function but Is Essential for Timely Axon Regeneration.	TUBB6 TUBB3	5.82e-04	21	59	2	30110642
Pubmed	The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex.	MAGEA1 TRIM41	5.82e-04	21	59	2	25590999
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	TRIM41 JRK SH3KBP1 GSPT1	5.97e-04	226	59	4	31452512
Pubmed	Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity.	TUBB6 TUBB3	6.39e-04	22	59	2	23826228
Pubmed	Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression.	TUBB6 TUBB3	6.39e-04	22	59	2	16526095
Pubmed	Bcl11a (Ctip1) Controls Migration of Cortical Projection Neurons through Regulation of Sema3c.	TUBB3 ZFPM2	6.39e-04	22	59	2	26182416
Pubmed	ISL1 controls pancreatic alpha cell fate and beta cell maturation.	TUBB3 FEV	6.39e-04	22	59	2	36899442
Pubmed	FGF signaling expands embryonic cortical surface area by regulating Notch-dependent neurogenesis.	TUBB3 ZFPM2	6.39e-04	22	59	2	22031906
Pubmed	TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology.	TUBB6 TUBB3	6.39e-04	22	59	2	30446499
Pubmed	A novel role for cilia-dependent sonic hedgehog signaling during submandibular gland development.	TUBB3 EGF	7.00e-04	23	59	2	29532549
Pubmed	KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer.	TUBB6 TUBB3 DYNC1H1	7.48e-04	104	59	3	36055981
Pubmed	Loss of Fgf9 in mice leads to pancreatic hypoplasia and asplenia.	TUBB3 FEV	7.62e-04	24	59	2	37096042
Pubmed	Patterned expression of ion channel genes in mouse dorsal raphe nucleus determined with the Allen Mouse Brain Atlas.	CACNA1A TTYH3	7.62e-04	24	59	2	22534482
Pubmed	The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis.	TUBB3 SIGMAR1 ELP2 ABHD17C	8.07e-04	245	59	4	19521500
Pubmed	Gata2 and Gata3 regulate the differentiation of serotonergic and glutamatergic neuron subtypes of the dorsal raphe.	TUBB3 FEV	9.66e-04	27	59	2	27789623
Pubmed	Maternal DNA Methylation Regulates Early Trophoblast Development.	STK10 PLCB4	1.04e-03	28	59	2	26812015
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TAOK2 CACNA1A TUBB6 SH3KBP1 TNRC6B DYNC1H1 FBXO2	1.19e-03	963	59	7	28671696
Pubmed	Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.	TUBB6 TUBB3	1.19e-03	30	59	2	25864199
Pubmed	Large-scale identification of human genes implicated in epidermal barrier function.	EGF SH2D3C	1.19e-03	30	59	2	17562024
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	KIAA1671 STK10 LGMN PLCB4 TTYH3 GSPT1	1.36e-03	719	59	6	35337019
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	TUBB6 STK10 TUBB3 DYNC1H1	1.39e-03	284	59	4	29459677
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	TAOK2 MAGEA1 TUBB6 GATD3 SH3KBP1 MARVELD3 USP48 FBXO2	1.47e-03	1293	59	8	15342556
Pubmed	Genome-wide association study of antibody response to smallpox vaccine.	FEV ABHD17C	1.53e-03	34	59	2	22542470
Pubmed	Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease.	TUBB3 DYNC1H1	1.53e-03	34	59	2	25915474
Pubmed	HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP.	DYNC1H1 ZNF169	1.53e-03	34	59	2	25925205
Pubmed	Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking.	TUBB6 TUBB3	1.62e-03	35	59	2	22337587
Cytoband	12p13.33	ITFG2 B4GALNT3	2.74e-04	19	59	2	12p13.33
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZSCAN29 ZNF671 ZFHX2 ZNF213 ZNF691 ZNF169 ZFPM2	1.05e-03	718	41	7	28
GeneFamily	Tubulins	TUBB6 TUBB3	1.58e-03	26	41	2	778
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	TAOK2 ZNF213 BRICD5 ZNF691 FBXO2	4.07e-06	180	59	5	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIAA1671 SH2D3C EXOC3L1 PLCB4 ZFPM2	5.30e-06	190	59	5	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4 ZFPM2	5.72e-06	193	59	5	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4 ZFPM2	5.87e-06	194	59	5	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4 ZFPM2	5.87e-06	194	59	5	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA1671 UNC5A SH2D3C PLCB4 ZFPM2	6.48e-06	198	59	5	b3a020522e064bb61949d38e442f24026e339364
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA1671 UNC5A SH2D3C PLCB4 ZFPM2	6.48e-06	198	59	5	fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872
ToppCell	droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUBB6 STK10 EGF PLAUR	6.02e-05	160	59	4	0b8151037b28f52a21918856a1e9336e8d5edb90
ToppCell	droplet-Lung-nan-21m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TUBB6 STK10 EGF PLAUR	6.02e-05	160	59	4	4738d0c73d8c3508e5b5beb6c61e0ad551d9b949
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TUBB6 UNC5A SH2D3C ZFPM2	6.63e-05	164	59	4	a784f47f67a5eda84d58ad7d9400e3978edbb487
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TUBB6 UNC5A SH2D3C ZFPM2	6.63e-05	164	59	4	1a1795969673232191425dde84ab24ee6a98143f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TUBB6 UNC5A SH2D3C ZFPM2	6.63e-05	164	59	4	8f074940afdbda88a4b697a7ddc687e09a4b818b
ToppCell	facs-Marrow-T_cells-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN MARVELD3 FBXO2 CHRND	8.15e-05	173	59	4	e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807
ToppCell	facs-Marrow-T_cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN MARVELD3 FBXO2 CHRND	8.33e-05	174	59	4	3b1ee39e85e5f0d6b17fb3051dbfae66cb2be6ee
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Control / Condition, Lineage and Cell class	LGMN TUBB3 KCNJ5 TTYH3	8.33e-05	174	59	4	4c64ff5666812fb4efa440ba4faeca51d916d68e
ToppCell	facs-Heart-RA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPN3 UNC5A PLAUR TMC4	9.70e-05	181	59	4	c68d272eb41f81bd8ea4d0360733a2396bc87037
ToppCell	facs-Heart-RA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPN3 UNC5A PLAUR TMC4	9.70e-05	181	59	4	5e5eb89f224ee48065a328ade030cbc4dcdcac12
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	UNC5A LGMN PLAUR TTYH3	1.01e-04	183	59	4	745271bfe15e94a58157cd97d771e610f964341b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUBB6 LGMN PLCB4 ATP13A2	1.01e-04	183	59	4	3b123571e10c132227aff65648b4b3c6acb4bd00
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TUBB6 LGMN PLCB4 ATP13A2	1.01e-04	183	59	4	df6fd0927b6e4cf9a1583969a68096e4bccfbace
ToppCell	3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A FEV MARVELD3 CHRND	1.06e-04	185	59	4	2088e82e0febdcf05618d3db913d00e2e87812f4
ToppCell	facs-Heart-LA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCRN2 TMC4 MARVELD3 FBXO2	1.08e-04	186	59	4	246503fd4e6ae24041c606b069eb5fb313e60f73
ToppCell	facs-Heart-LA-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCRN2 TMC4 MARVELD3 FBXO2	1.08e-04	186	59	4	ef93ac469eb4f63db036f14b442c1503b8c6de38
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LGMN ZNF213 ATP13A2 UTY	1.10e-04	187	59	4	d3563bb087e476baea5b59389e4d34d0ff98cac5
ToppCell	Leuk-UTI-Myeloid-pDC\|Leuk-UTI / Disease, Lineage and Cell Type	TUBB6 LGMN PLCB4 ATP13A2	1.10e-04	187	59	4	e3035b1f65ab12b8f01799b8e5d6633b9b584a06
ToppCell	droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNJ5 EXOC3L1 PLAUR FEV	1.12e-04	188	59	4	51c6796a9488c056a10d048082015342c2e037f9
ToppCell	droplet-Kidney-KIDNEY-1m-Endothelial-kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KCNJ5 EXOC3L1 PLAUR FEV	1.12e-04	188	59	4	b651024d58ed1bcfe0d80b21755f8bf709eda81f
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	KIAA1671 SH2D3C PLCB4 ZFPM2	1.12e-04	188	59	4	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.12e-04	188	59	4	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIAA1671 SH2D3C PLCB4 ZFPM2	1.12e-04	188	59	4	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC\|lymph-node_spleen / Manually curated celltypes from each tissue	TUBB6 LGMN PLAUR ATP13A2	1.15e-04	189	59	4	6c2ace61a7d62bcf7e76b73e2da8b722d03e713b
ToppCell	wk_20-22-Hematologic-Myeloid-APOE+_Mac2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LGMN KCNJ5 PLAUR TTYH3	1.15e-04	189	59	4	e189ef6066f87177d758f0e3ed9a17e01031a391
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.15e-04	189	59	4	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	Control-Myeloid-pDC\|Control / Disease group, lineage and cell class	TUBB6 LGMN PLCB4 ATP13A2	1.15e-04	189	59	4	46770b99da42f11f10cfc67cea8562342d60b867
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TUBB6 LGMN PLCB4 ATP13A2	1.17e-04	190	59	4	adffa93635da10251f28b2089fd96b189775c8b4
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUBB6 LGMN PLCB4 ATP13A2	1.17e-04	190	59	4	9a91bf1ea105029e6412d0d9060bca325299ce26
ToppCell	PBMC-Control-Myeloid-pDC-pDC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TUBB6 LGMN PLCB4 ATP13A2	1.17e-04	190	59	4	39c8ddc2639bf3e986dae11fbae61a735614b604
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIAA1671 SH2D3C PLCB4 ZFPM2	1.17e-04	190	59	4	0e9847d7f49b2236b8a191e1a7df37556351ba9e
ToppCell	PBMC-Control-Myeloid-pDC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUBB6 LGMN PLCB4 ATP13A2	1.17e-04	190	59	4	2c1c079fd411c03bc3f383aa927eea9446716960
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.17e-04	190	59	4	a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUBB6 LGMN PLCB4 ATP13A2	1.17e-04	190	59	4	a95aea3aa707fc4574810706341a5f32b3d00209
ToppCell	PBMC-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TUBB6 LGMN PLCB4 ATP13A2	1.17e-04	190	59	4	18dfa84c62dcf081ce9958a71e76a394ec0968e4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.17e-04	190	59	4	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.22e-04	192	59	4	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.22e-04	192	59	4	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.24e-04	193	59	4	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.24e-04	193	59	4	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.24e-04	193	59	4	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.24e-04	193	59	4	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.24e-04	193	59	4	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Control-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	LGMN SH3KBP1 PLAUR TTYH3	1.24e-04	193	59	4	2a6d531abd34df20941cf3dac4fdfb1621a1bde6
ToppCell	facs-Trachea-nan-3m-Epithelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPN3 TEKT1 TMC4 MARVELD3	1.27e-04	194	59	4	3701ca87c6dc9ccd7b4146e56371546174d26c36
ToppCell	facs-Trachea-nan-3m-Epithelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPN3 TEKT1 TMC4 MARVELD3	1.27e-04	194	59	4	65f9bf126be26114c2c3f4c46d48318986212a92
ToppCell	normal-na-Myeloid-plasmacytoid_dendritic_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TUBB6 LGMN PLCB4 ATP13A2	1.27e-04	194	59	4	74545942aded51a0f4ee96054b4ce12c4d99a8a0
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.27e-04	194	59	4	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 EXOC3L1 PLCB4 ZFPM2	1.27e-04	194	59	4	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA1671 SH2D3C EXOC3L1 PLCB4	1.27e-04	194	59	4	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STK10 LGMN KCNJ5 TTYH3	1.27e-04	194	59	4	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STK10 LGMN KCNJ5 TTYH3	1.29e-04	195	59	4	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	KIAA1671 SH2D3C PLCB4 ZFPM2	1.29e-04	195	59	4	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	Enterocyte-C_05\|Enterocyte / shred on cell type and cluster	SH3KBP1 PLAUR B4GALNT3 ABHD17C	1.32e-04	196	59	4	c307e5a70186567c62da938caa21749dc0e929d0
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	KIAA1671 SH2D3C PLCB4 ZFPM2	1.32e-04	196	59	4	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KIAA1671 SH2D3C PLCB4 ZFPM2	1.34e-04	197	59	4	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	3'_v3-Lung-Myeloid_Mac-Intermediate_macrophages\|Lung / Manually curated celltypes from each tissue	TUBB6 TUBB3 PLAUR TTYH3	1.34e-04	197	59	4	bcb4dc17dae705bd84ea6a2842d6b107562baeb7
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	STK10 LGMN PLAUR TTYH3	1.37e-04	198	59	4	2e470249edc7cf85bed550795ff84cbef22895c0
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KIAA1671 CACNA1A TUBB3 ZFHX2	1.37e-04	198	59	4	d6812494874be0c14361ac2ac3e418b335bb8f55
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	STK10 LGMN PLAUR TTYH3	1.40e-04	199	59	4	667b8b47a5b388506e3177b46747267fad8024f6
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LGMN KCNJ5 PLAUR TTYH3	1.40e-04	199	59	4	f987f48970aec46156b80656e49b9f3604f3758c
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STK10 SH2D3C PLAUR TTYH3	1.42e-04	200	59	4	fd72fe6565e2f4885481991492d58c323ab1ad40
ToppCell	Mild-Myeloid-Macrophages-FCN1-SPP1+\|Mild / Condition, Lineage, Cell class and cell subclass	LGMN KCNJ5 PLAUR TTYH3	1.42e-04	200	59	4	e5afd8e2cb2c63899d49fe17011f474d20bb06ea
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_other\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LGMN KCNJ5 PLAUR TTYH3	1.42e-04	200	59	4	2d2835f97e0ff4f99d384f18e10876575f6bdefd
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NPHS1 ZFPM2 IL27RA	2.89e-04	97	59	3	0d68bf2dfb9c221375b70b055f735536afb18f65
Disease	migraine with aura (is_implicated_in)	CACNA1A MTHFR	5.47e-05	6	57	2	DOID:10024 (is_implicated_in)
Disease	Childhood Absence Epilepsy	CACNA1A JRK	7.65e-05	7	57	2	C4281785
Disease	Epilepsy, Minor	CACNA1A JRK	7.65e-05	7	57	2	C4552765
Disease	Absence Epilepsy	CACNA1A JRK	7.65e-05	7	57	2	C0014553
Disease	Akinetic Petit Mal	CACNA1A JRK	7.65e-05	7	57	2	C0001890
Disease	Epilepsy, Absence, Atypical	CACNA1A JRK	7.65e-05	7	57	2	C0751124
Disease	Absence Seizure Disorder	CACNA1A JRK	7.65e-05	7	57	2	C4553705
Disease	Juvenile Absence Epilepsy	CACNA1A JRK	7.65e-05	7	57	2	C4317339
Disease	migraine (is_implicated_in)	CACNA1A MTHFR	1.31e-04	9	57	2	DOID:6364 (is_implicated_in)
Disease	facial paralysis (implicated_via_orthology)	TUBB6 TUBB3	1.63e-04	10	57	2	DOID:13934 (implicated_via_orthology)
Disease	complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology)	TUBB6 TUBB3	1.63e-04	10	57	2	DOID:0090132 (implicated_via_orthology)
Disease	ptosis (implicated_via_orthology)	TUBB6 TUBB3	1.63e-04	10	57	2	DOID:0060260 (implicated_via_orthology)
Disease	tubulinopathy (implicated_via_orthology)	TUBB6 TUBB3	1.63e-04	10	57	2	DOID:0112227 (implicated_via_orthology)
Disease	autosomal dominant nonsyndromic deafness (is_implicated_in)	USP48 EPHA10	1.99e-04	11	57	2	DOID:0050564 (is_implicated_in)
Disease	Hyperhomocysteinemia	NPHS1 MTHFR	1.99e-04	11	57	2	C0598608
Disease	cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology)	TUBB6 TUBB3	2.39e-04	12	57	2	DOID:0050997 (implicated_via_orthology)
Disease	advanced glycosylation end product-specific receptor, soluble measurement	B4GALNT3 ZFPM2	2.82e-04	13	57	2	EFO_0020131
Disease	tetralogy of Fallot (is_implicated_in)	MTHFR ZFPM2	2.82e-04	13	57	2	DOID:6419 (is_implicated_in)
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	TNRC6B ZFPM2	5.50e-04	18	57	2	EFO_1000649, HP_0000131
Disease	Kidney Diseases	NPHS1 EGF MTHFR	6.68e-04	88	57	3	C0022658
Disease	nephrotic syndrome (implicated_via_orthology)	NPHS1 SH3KBP1	9.85e-04	24	57	2	DOID:1184 (implicated_via_orthology)
Disease	Alcoholic Intoxication, Chronic	GHSR EGF SIGMAR1 MTHFR	1.80e-03	268	57	4	C0001973
Disease	peptic ulcer disease	JRK ZNF169	1.86e-03	33	57	2	MONDO_0004247

Protein segments in the cluster

Peptide	Gene	Start	Entry
WEGEAERGKAGDPHR	CACNA1A	916	O00555
ALDGEVAEWGREHGP	EXOC3L1	396	Q86VI1
DPEGFTENGEWEIVH	CHRND	201	Q07001
QAPGRGWHGEEEVVA	B4GALNT3	581	Q6L9W6
GWHGEEEVVAAAGQE	B4GALNT3	586	Q6L9W6
GWFEELGAEPLEIHG	BRICD5	211	Q6PL45
PALAWEREDTHGGVG	DNM1P46	111	Q6ZS02
IAWEGGHGEFKLTDP	FEV	66	Q99581
EHEKEVRSWQGDGSP	EPN3	251	Q9H201
GDLDHVGDQEWIPCV	KCNJ5	116	P48544
EWPGLDEGHVRAGQS	NPHS1	246	O60500
DGEEGIPVQVDGEAW	DGKK	1001	Q5KSL6
LRGDPIGDQWEEEEG	MTHFR	156	P42898
GGHAPEEEIWEELSV	MAGEA1	206	P43355
GRGEEDSVAQWGDHP	KIAA1671	1381	Q9BY89
EVTVGHEQEEGGKWP	GATD3B	191	A0A0B4J2D5
GVETDDWDGPGELEV	ZFPM2	91	Q8WW38
GLVPEGGVEEERDHW	FBXO2	96	Q9UK22
RGDPGEGEEVAWEQA	JRK	476	O75564
GEPLEHVVDWARDGD	IL27RA	346	Q6UWB1
NGWEEISGVDEHDRP	EPHA10	56	Q5JZY3
GDRQPTVVGEEWVDD	CRNN	431	Q9UBG3
WEHKEEISEAEPGGG	GSPT1	21	P15170
RWEELGEGPEHLTGQ	ITFG2	156	Q969R8
GGEEEWVDSSELVPG	ATP13A2	301	Q9NQ11
LVGVEHENGTDPWDT	GHSR	181	Q92847
EEGVDVPEGLAVDWI	EGF	551	P01133
EPLWVEGAGHNDIEL	ABHD17C	296	Q6PCB6
DAGPRAGEHGVWEKP	MARVELD3	96	Q96A59
EVTVGHEQEEGGKWP	GATD3	191	P0DPI2
EDVLGKGWENHVEGQ	DYNC1H1	666	Q14204
GHFDGVQDLVWDPEG	ELP2	386	Q6IA86
LHDIRKPEGQGWESG	FTH1P19	46	P0C7X4
GKEVIWHGRTNDEPA	UTY	1261	O14607
EEVEAVGAGAGWDTP	TRIM41	71	Q8WV44
CWDGKGEDQEPIITH	PLCB4	361	Q15147
GNEAVWTKEPVGEGE	SCRN2	96	Q96FV2
VGDIIEVVGEVEEGW	SH3KBP1	121	Q96B97
TVVHGPGEATAVEWG	SIGMAR1	151	Q99720
SIPLRDGEDHGVWAG	TEKT1	396	Q969V4
HGSLVDEEVWGLPEE	TAOK2	831	Q9UL54
EVRPGRAWEEHQAVG	SH3TC2	401	Q8TF17
EHPRWEENCEEEAGG	SYCE2	26	Q6PIF2
IDGEAEDGEQGPIWT	STK25	306	O00506
GLRPGCWHGVEDEEV	ZNF671	126	Q8TAW3
DVVTHWIQEGEEGRP	PLAUR	146	Q03405
WIQEGEEGRPKDDRH	PLAUR	151	Q03405
EEGEGGKPWRVDDSE	ZNF691	46	Q5VV52
AGGHWPIEEEESSRG	ZFHX2	1571	Q9C0A1
WEVISDEHGIDPAGG	TUBB6	21	Q9BUF5
VLPWGALEEEEEDGG	TMC4	56	Q7Z404
DPNEVWEIVGELGDG	STK10	31	O94804
WEVISDEHGIDPSGN	TUBB3	21	Q13509
EGSWEDVLHLGEEAP	UNC5A	541	Q6ZN44
IQGWVREQHPGSGEE	ZNF213	101	O14771
EGPEPWGSTEHGVEV	SH2D3C	761	Q8N5H7
EPGQRGWQHEEGAEE	ZSCAN29	361	Q8IWY8
VGIGEHIWLGEIDEN	USP48	56	Q86UV5
HTWQQKRGPDEDGEE	TTYH3	411	Q9C0H2
DPVEWVEGNREGGTD	ZNF169	171	Q14929
GARHPSWEEEEDGGV	TNRC6B	1006	Q9UPQ9
GVESVPEEGILEAWG	nan	71	A6NHS1
GAVPIDDPEDGGKHW	LGMN	16	Q99538
DDPEDGGKHWVVIVA	LGMN	21	Q99538